Related Experiment Video
Updated: Aug 21, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Microalbuminuria: definition, detection, and clinical significance
1University of Texas Southwestern Medical Center-Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-8856, USA. robert.toto@utsouthwestern.edu
Abstract:
Proteinuria is a sign of abnormal excretion of protein by the kidney but is a nonspecific term including any or all proteins excreted. In contrast, albuminuria specifically refers to an abnormal excretion rate of albumin. Microalbuminuria refers to an abnormally increased excretion rate of albumin in the urine in the range of 30-299 mg/g creatinine. It is a marker of endothelial dysfunction and increased risk for cardiovascular morbidity and mortality especially, but not exclusively, in high-risk populations such as diabetics and hypertensives. Testing for microalbuminuria is now made easy by in-office dipstick tests (semiquantitative) and widely available laboratory testing (quantitative). Physicians should screen all diabetics for albuminuria and strongly consider screening hypertensives to identify those at higher risk for cardiovascular disease. Appropriate intervention, including use of drugs that block the renin-angiotensin-aldosterone system, may be appropriate in such cases as suggested by the American Diabetes Association and the Seventh Report of Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Insights
Microalbuminuria, an early sign of kidney issues, indicates increased albumin excretion and predicts higher cardiovascular risk, especially in diabetics and hypertensives. Early screening and intervention are recommended.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Proteinuria signifies abnormal kidney protein excretion, while albuminuria specifically denotes excess albumin.
- Microalbuminuria, defined as 30-299 mg/g creatinine albumin excretion, is a key indicator of endothelial dysfunction.
Purpose of the Study:
- To highlight microalbuminuria as a marker for cardiovascular morbidity and mortality risk.
- To emphasize the importance of screening high-risk populations like diabetics and hypertensives for albuminuria.
Main Methods:
- Utilizing readily available in-office dipstick tests (semiquantitative) and laboratory tests (quantitative) for microalbuminuria detection.
- Reviewing current screening recommendations for diabetic and hypertensive patients.
Main Results:
- Microalbuminuria is a significant predictor of cardiovascular morbidity and mortality, particularly in diabetic and hypertensive individuals.
- Screening for albuminuria is feasible with current diagnostic tools.
Conclusions:
- Physicians should screen all diabetic patients for albuminuria and consider screening hypertensive patients.
- Early detection of microalbuminuria can guide interventions, such as renin-angiotensin-aldosterone system blockade, to mitigate cardiovascular risk.
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
Urine Studies I: Urinalysis
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome I : Introduction